SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc

<< Previous

Bullboard Posts

Next >>

Post by mercedesmanon Jul 26, 2021 11:21am

165 Views

Post# 33604348

Loving these fills...

at sub .18 !!

Never thought I'd get them this cheap after AZOVA Distribution Agreement news a week or so ago.

Got a bit more to buy....please don't make me have to pay .18 or .19 !

Just 1/4 of 1% market penetration on the CV-19 antibody test (for US market only) yields a conservative .66/sh (= 4 bagger) estimated share price.

Of course the (1) accuracy of their test, the (2) head start they have on the science, and (3) multiplexing capatilbities (test for other things besides CV or perhaps various strains)....makes me think that the market penetration will ultimately be MUCH MUCh higher.

MM

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing